We've found
4,191
archived clinical trials in
Constipation
We've found
4,191
archived clinical trials in
Constipation
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials